“…Moreover, histone hyperacetylation in donor cells and/or SCNT embryos could improve their further developmental competence (Enright, Kubota, Yang, & Tian, ; Li et al., ; Wang, Xiong, et al., ). Currently, research reports showed that the level of histone acetylation and cloning development can be increased by histone deacetylase inhibitors (HDACis) such as trichostatin A (TSA) (Iager et al., ; Kishigami et al., ; Luo et al., ; Yamanaka, Sugimura, Wakai, Kawahara, & Sato, ), scriptaid (Van Thuan et al., ; Wang, Zhang, et al., ; Zhao et al., ) and valproic acid (VPA) (Costa‐Borges, Gonzalez, Santalo, & Ibanez, ; Miyoshi et al., ; Xu et al., ). These HDACis such as TSA and scriptaid, with their hydroxamic acid group and five‐carbon atom linker to the phenyl group, had the optimal conformation to fit into the active site which specifically binds zinc‐dependent hydrolases of histone deacetylases (HDACs) (Finnin et al., ).…”